Hope for Alzheimer's agitation: new drug in Late-Stage trial
Symptom relief
Recruiting now
This study tests an experimental drug called masupirdine to see if it can safely reduce agitation in people with Alzheimer's dementia. About 375 participants will receive either the drug or a placebo. The goal is to improve quality of life by calming symptoms like aggression and …
Phase: PHASE3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC